Namho was previously a management consultant at McKinsey & Company and Boston Consulting Group. He was a core member of the Life Sciences Practice, in which he successfully led significant projects across various healthcare domains including clinical development strategies, building new businesses, transformative commercial initiatives, and digital innovation for multinational biopharma, Korean biotechs, and conglomerates.

Prior to his management consulting career, Namho was a biomedical researcher in various academic and institutional settings. Namho holds a Ph.D. in Chemical and Biomolecular Engineering from Johns Hopkins University, where his research involved developing novel gene delivery technologies to treat obstructive lung diseases and neurodegenerative diseases such as cystic fibrosis and Parkinson’s disease, respectively. He also earned an M.S. in Biomedical Engineering from Purdue University and a B.S. in Bioengineering from Lehigh University. 

He was also a research scientist at Korea Institute of Science and Technology, a premier multidisciplinary research institute. His substantial research contributions include 16 peer-reviewed publications in the fields of nanomedicine and gene therapy.